The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-[[4-[4-(azetidin-3-ylamino)-3-methyl-pyrazol-1-yl]pyrimidin-2-yl]amino]-N,1-dimethyl-indazole-3-carboxamide ID: ALA4743842
PubChem CID: 162645572
Max Phase: Preclinical
Molecular Formula: C21H24N10O
Molecular Weight: 432.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1nn(C)c2ccc(Nc3nccc(-n4cc(NC5CNC5)c(C)n4)n3)cc12
Standard InChI: InChI=1S/C21H24N10O/c1-12-16(25-14-9-23-10-14)11-31(28-12)18-6-7-24-21(27-18)26-13-4-5-17-15(8-13)19(20(32)22-2)29-30(17)3/h4-8,11,14,23,25H,9-10H2,1-3H3,(H,22,32)(H,24,26,27)
Standard InChI Key: RQGFXPAVLAGNDK-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
30.0489 -7.6931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0478 -8.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7558 -8.9216 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4655 -8.5122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4627 -7.6895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7540 -7.2843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1738 -8.9197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8809 -8.5100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5859 -8.9179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2925 -8.5089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8747 -7.6948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5784 -7.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2878 -7.6916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8952 -7.1430 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5611 -6.3958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7473 -6.4827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1996 -5.8762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4509 -5.0986 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4005 -6.0474 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2499 -4.9275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6948 -7.3117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7516 -6.4671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4118 -5.9848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1569 -5.2084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3397 -5.2108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0896 -5.9888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6353 -4.5458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8573 -4.5512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3007 -3.8003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5957 -3.0371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8319 -2.7466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5413 -3.5103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 13 2 0
12 11 2 0
11 8 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 12 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
14 21 1 0
6 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 22 1 0
24 27 1 0
25 28 1 0
27 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 432.49Molecular Weight (Monoisotopic): 432.2135AlogP: 1.34#Rotatable Bonds: 6Polar Surface Area: 126.61Molecular Species: BASEHBA: 10HBD: 4#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.70CX Basic pKa: 9.09CX LogP: 0.88CX LogD: -0.80Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.36Np Likeness Score: -1.63
References 1. Barlaam B,Boiko S,Boyd S,Dry H,Gingipalli L,Ikeda T,Johnson T,Kawatkar S,Lorthioir O,Pike A,Pollard H,Read J,Su Q,Wang H,Wang H,Wang L,Wang P,Edmondson SD. (2020) Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors., 30 (22): [PMID:32877741 ] [10.1016/j.bmcl.2020.127523 ]